|
ACBD7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6304735339645E-12 |
| Normal-vs-Stage2 |
2.25020002631027E-11 |
| Normal-vs-Stage3 |
1.77635683940025E-15 |
| Normal-vs-Stage4 |
8.56759999945389E-07 |
| Stage1-vs-Stage2 |
9.967200E-01 |
| Stage1-vs-Stage3 |
9.720800E-01 |
| Stage1-vs-Stage4 |
4.784000E-02 |
| Stage2-vs-Stage3 |
9.762400E-01 |
| Stage2-vs-Stage4 |
9.166100E-02 |
| Stage3-vs-Stage4 |
3.984300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.99200722162641E-16 |
| Normal-vs-AfricanAmerican |
2.952200E-02 |
| Normal-vs-Asian |
2.22044604925031E-16 |
| Caucasian-vs-AfricanAmerican |
2.607200E-01 |
| Caucasian-vs-Asian |
5.139600E-02 |
| AfricanAmerican-vs-Asian |
1.413560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.92323934555816E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
2.537600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.5512800000006E-05 |
| Normal-vs-Age(41-60Yrs) |
2.80375722638837E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(81-100Yrs) |
1.64812608005604E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.229600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.050600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.217780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.999800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.118650E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.220800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.03660000033901E-07 |
| Normal-vs-Grade 2 |
1.62470037423645E-12 |
| Normal-vs-Grade 3 |
3.75566244770198E-12 |
| Normal-vs-Grade 4 |
1.16500000002517E-06 |
| Grade 1-vs-Grade 2 |
5.792400E-01 |
| Grade 1-vs-Grade 3 |
8.984600E-01 |
| Grade 1-vs-Grade 4 |
3.064200E-01 |
| Grade 2-vs-Grade 3 |
2.878800E-01 |
| Grade 2-vs-Grade 4 |
5.291500E-02 |
| Grade 3-vs-Grade 4 |
2.936400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
5.45470002499826E-10 |
| ccA subtype-vs-ccB subtype |
1.353700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.71080943750712E-12 |
| Normal-vs-N1 |
4.392000E-01 |
| N0-vs-N1 |
3.540100E-02 |
|
|
